Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3191-3201
Author(s):
Lara Sanvito, Cris S. Constantinescu and Bruno Gran
Overlooked Issues of Snakebite Management: Time for Strategic Approach
Journal:
Current Topics in Medicinal Chemistry
Volume:
11
Page:
2494-2508
Author(s):
K. S. Girish and K. Kemparaju
Autoimmune Neuromuscular Disorders
Journal:
Current Neuropharmacology
Volume:
9
Page:
400-408
Author(s):
Jessica Kraker and Sasa A. zivkovic
Idiopathic Transverse Myelitis and Neuromyelitis Optica: Clinical Profiles,Pathophysiology and Therapeutic Choices
Journal:
Current Neuropharmacology
Volume:
9
Page:
417-428
Author(s):
Amer Awad and Olaf Stuve
Neurosarcoidosis
Journal:
Current Neuropharmacology
Volume:
9
Page:
429-436
Author(s):
David Lacomis
Central Nervous System Vasculitis: Still More Questions than Answers
Journal:
Current Neuropharmacology
Volume:
9
Page:
437-448
Author(s):
Marco A. Alba, Georgina Espigol-Frigole, Sergio Prieto-Gonzalez, Itziar Tavera-Bahillo, Ana Garcia-Martinez, Montserrat Butjosa, Jose Hernandez-Rodriguez and Maria C. Cid
Neuropsychiatric Systemic Lupus Erythematosus
Journal:
Current Neuropharmacology
Volume:
9
Page:
449-457
Author(s):
Alexandra Popescu and Amy H. Kao
Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Journal:
Current Neuropharmacology
Volume:
9
Page:
468-477
Author(s):
Enrico C. Lallana and Camilo E. Fadul
Acute Severe Colitis: Infliximab and/or Cyclosporine?
Journal:
Current Drug Targets
Volume:
12
Page:
1448-1453
Author(s):
Mauro Fabro, Hajnalka Szabo, Giovanni Terrosu, Claudio Avellini, Maria Tabuso, Gionata Fiorino and Dario Sorrentino
Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Journal:
Current Drug Targets
Volume:
12
Page:
1498-1512
Author(s):
Georgios S. Papaetis, Dora Orphanidou and Themistoklis N. Panagiotou